Medicare Program; Manufacturer Submission of Manufacturer's Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals

Summary

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) mandates manufacturers to submit their average sales price (ASP) data for Medicare Part B drugs and biologicals, and this final rule addresses public comments on the methodology for estimating price concessions.